SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Mudcat who wrote (20759)5/14/1998 12:01:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
There are two Tamoxifen/Panretin combo trials that have been underwritten by the government (see home.att.net for details) . One of the investigators will be presenting initial Phase I (/II?) data at ASCO next week.